About this page
Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.
How to read it
- Form 4
- The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
- Buy (P) and Sell (S)
- Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
- Value
- Shares times price, as reported on the filing.
- 10b5-1
- A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
- Late filing
- A Form 4 filed more than two business days after the trade.
- Vs. S&P 500
- How the stock did after the trade minus how the overall market did in the same weeks.
A real example
In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.
Explain it like I'm 13
If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.
Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.
Hims & Hers Health, Inc. (HIMS) Insider Trading
22 open-market trades reported since Jun 17, 2026: 0 purchases worth $0 and 22 sales worth $9.60M.
By insider
| Insider | Role | Buys | Bought | Sells | Sold |
|---|---|---|---|---|---|
| Soleil Boughton | General Counsel | 0 | $0 | 5 | $1.17M |
| Oluyemi Okupe | CFO | 0 | $0 | 9 | $4.75M |
| Michael Chi | COO | 0 | $0 | 2 | $840K |
| Mohamed Elshenawy | CTO | 0 | $0 | 2 | $1.17M |
| Deborah M. Autor | Chief Policy Officer | 0 | $0 | 1 | $467K |
| Patrick Harrison Carroll | Chief Medical Officer | 0 | $0 | 1 | $830K |
| Irene Becklund | PAO | 0 | $0 | 2 | $371K |
All trades
| Filed | Insider | Type | Value | 3 mo. after |
|---|---|---|---|---|
| Oct 15 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $101K | |
| Oct 2 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $101K | |
| Oct 2 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $59K | |
| Sep 23 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $877K | |
| Sep 18 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $355K | |
| Sep 17 | Michael ChiCOO | ▼ SELL10b5-1 | $398K | |
| Sep 17 | Mohamed ElshenawyCTO | ▼ SELL10b5-1 | $226K | |
| Sep 17 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $174K | |
| Sep 3 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $98K | |
| Aug 20 | Soleil BoughtonGeneral Counsel | ▼ SELL10b5-1 | $692K | |
| Aug 20 | Deborah M. AutorChief Policy Officer | ▼ SELL10b5-1 | $467K | |
| Aug 20 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $148K | |
| Aug 18 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $1.94M | |
| Aug 18 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $262K | |
| Jul 20 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $229K | |
| Jul 7 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $261K | |
| Jun 23 | Patrick Harrison CarrollChief Medical Officer | ▼ SELL10b5-1 | $830K | |
| Jun 23 | Oluyemi OkupeCFO | ▼ SELL10b5-1 | $619K | |
| Jun 17 | Mohamed ElshenawyCTO | ▼ SELL10b5-1 | $946K | |
| Jun 17 | Michael ChiCOO | ▼ SELL10b5-1 | $442K | |
| Jun 17 | Irene BecklundPAO | ▼ SELL10b5-1 | $229K | |
| Jun 17 | Irene BecklundPAO | ▼ SELL10b5-1 | $141K |